C. difficile infections fell during pandemic, but patients had higher mortality, costs

Although the prevalence of Clostridioides difficile infection in the U.S. continued its long-term downward trend during the COVID-19 pandemic, patients who were infected saw high treatment costs and increased mortality, a study found.The researchers found that patients diagnosed with C. difficile infection (CDI) during the pandemic had more severe illness, possibly because of changes in health care delivery — namely, that these were the only patients who would have been admitted.“It is possible that patients who developed CDI in the outpatient setting may not have received asRead More